Validus (NYSE:VR) was downgraded by investment analysts at Keefe, Bruyette & Woods from an “outperform” rating to a “market perform” rating in a research note issued on Monday, The Fly reports.

Several other research firms have also weighed in on VR. UBS Group upped their price objective on Validus from $48.00 to $52.00 and gave the company a “neutral” rating in a research note on Monday, October 30th. Bank of America upgraded Validus from a “neutral” rating to a “buy” rating in a research note on Monday, October 30th. ValuEngine lowered Validus from a “buy” rating to a “hold” rating in a research note on Wednesday, October 11th. Zacks Investment Research reiterated a “strong sell” rating on shares of Validus in a research note on Saturday, January 6th. Finally, TheStreet lowered Validus from a “b” rating to a “c+” rating in a research note on Wednesday, October 11th. Two investment analysts have rated the stock with a sell rating, five have given a hold rating and three have issued a buy rating to the company. The company currently has a consensus rating of “Hold” and a consensus price target of $54.33.

Validus (NYSE VR) traded up $20.57 during trading on Monday, reaching $67.29. The company’s stock had a trading volume of 30,805,862 shares, compared to its average volume of 2,779,072. The company has a debt-to-equity ratio of 0.52, a quick ratio of 0.95 and a current ratio of 0.95. The firm has a market cap of $3,712.46, a PE ratio of -103.52, a price-to-earnings-growth ratio of 1.26 and a beta of 0.67. Validus has a 12-month low of $41.15 and a 12-month high of $67.60.

Validus (NYSE:VR) last released its quarterly earnings data on Thursday, October 26th. The insurance provider reported ($3.22) earnings per share for the quarter, beating the consensus estimate of ($3.30) by $0.08. Validus had a negative return on equity of 0.49% and a negative net margin of 1.38%. The company had revenue of $407.00 million for the quarter, compared to analyst estimates of $453.04 million. During the same period in the prior year, the company posted $1.02 EPS. The company’s revenue was up 24.3% compared to the same quarter last year. sell-side analysts expect that Validus will post -0.3 earnings per share for the current year.

In related news, President Kean Driscoll sold 6,875 shares of the stock in a transaction that occurred on Wednesday, November 15th. The stock was sold at an average price of $50.30, for a total transaction of $345,812.50. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, CEO Lixin Zeng sold 26,136 shares of the stock in a transaction that occurred on Wednesday, November 1st. The stock was sold at an average price of $52.10, for a total value of $1,361,685.60. Following the sale, the chief executive officer now owns 57,855 shares in the company, valued at $3,014,245.50. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 46,761 shares of company stock worth $2,346,461. 2.33% of the stock is owned by corporate insiders.

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in VR. SG Americas Securities LLC bought a new stake in Validus during the 2nd quarter worth approximately $116,000. BNP Paribas Arbitrage SA lifted its holdings in Validus by 93.7% during the 2nd quarter. BNP Paribas Arbitrage SA now owns 2,650 shares of the insurance provider’s stock worth $138,000 after buying an additional 1,282 shares in the last quarter. TIAA CREF Investment Management LLC lifted its holdings in Validus by 1.1% during the 2nd quarter. TIAA CREF Investment Management LLC now owns 297,182 shares of the insurance provider’s stock worth $15,445,000 after buying an additional 3,185 shares in the last quarter. Ameriprise Financial Inc. lifted its holdings in Validus by 1.9% during the 2nd quarter. Ameriprise Financial Inc. now owns 359,838 shares of the insurance provider’s stock worth $18,700,000 after buying an additional 6,775 shares in the last quarter. Finally, BlackRock Inc. lifted its holdings in Validus by 11.2% during the 2nd quarter. BlackRock Inc. now owns 3,597,480 shares of the insurance provider’s stock worth $186,963,000 after buying an additional 361,617 shares in the last quarter. Institutional investors and hedge funds own 96.29% of the company’s stock.

COPYRIGHT VIOLATION WARNING: “Validus (VR) Downgraded by Keefe, Bruyette & Woods” was posted by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this story on another site, it was illegally copied and republished in violation of international copyright law. The correct version of this story can be accessed at https://www.thecerbatgem.com/2018/01/22/validus-vr-downgraded-by-keefe-bruyette-woods.html.

About Validus

Validus Holdings, Ltd. is a holding company. The Company operates through four segments: Validus Re, Talbot, Western World and AlphaCat. Validus Re is a Bermuda-based reinsurance segment focused treaty reinsurance. Validus Re concentrates on first-party property and other reinsurance risks. Talbot is a specialty insurance segment operating within the Lloyd’s insurance market through Syndicate 1183.

The Fly

Analyst Recommendations for Validus (NYSE:VR)

Receive News & Ratings for Validus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Validus and related companies with MarketBeat.com's FREE daily email newsletter.